Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Intellectual Property Watch

Intellectual Property Law

: Intellectual Property Watch

Genetics Company Myriad May Shift From Patents To Proprietary Data

By Intellectual Property Watch

Myriad Genetics, a United States-based biotechnology company with exclusive patent rights over a key breast cancer diagnostic test in the US, may shift its patent strategy from its inventions to protecting its data in the face of drawn out litigation and upcoming competition, an industry journal has reported. Related Articles:Shareholders In 3G Mobile Patent Company Seek US Investigation Of Nokia, Ericsson Open Source Company Alleges IBM Antitrust; IBM Requests Analysis Economist: Breadth Of P read more

Full post as published by Intellectual Property Watch on March 03, 2011 (boomark / email).